PSP Research »

Ultragenyx Pharmaceutical shares owned by PSP Research

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $463k 22k 20.95

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
BlackRock
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Sofinnova Ventures
Sands Capital Management
Rtw Investments
FMR
Wellington Management Company
Citadel Advisors
Assenagon Asset Management
Two Sigma Investments
Frontier Capital Management

View all funds holding Ultragenyx Pharmaceutical